SynBioBeta Speaker
Sam Wadsworth
Chief Scientific Officer
Aspect Biosystems
As Chief Scientific Officer at Aspect Biosystems, Sam is responsible for the biological scientific innovation and development. He co-founded the company in 2013 and currently leads our technical efforts in developing cell-containing bioprinted tissues to treat currently incurable diseases. In 2023, based on highly promising pre-clinical data, Aspect partnered with Novo Nordisk to co-develop bioprinted tissue therapeutics for diabetes and obesity. This deal worth up to $2.6Bn + royalties, is the largest bioprinting deal ever, and one of the largest pre-clinical deals in Canadian history. Sam holds a PhD in respiratory cell biology from the University of Nottingham."
SynBioBeta 2025 - Session Speaker
Synthetic Biology Frontiers in Transplantation: Engineering Durable Therapeutic Solutions
This cutting-edge session explores the intersection of synthetic biology, materials science, and transplantation medicine to address key challenges in cell, tissue, and organ transplantation. We'll examine innovative approaches to enhance transplant durability, improve integration with host systems, and advance the field of regenerative medicine. Examples include: genetically engineered cells for enhanced survival, 3d-printed scaffolds and organoids, advances in xenotransplantation, and others.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
08:05:55:40
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates